CBS Antibody

What is CBS and why are antibodies against it important in research?

CBS (cystathionine-beta-synthase) is a key enzyme in the transsulfuration pathway that catalyzes the condensation of homocysteine and serine to form cystathionine. This enzyme plays crucial roles in amino acid metabolism and cellular redox homeostasis. CBS antibodies are essential research tools that enable detection and quantification of this protein in various experimental systems. They allow researchers to investigate CBS expression patterns across different tissues, subcellular localization, and alterations in pathological conditions. High-quality, well-validated antibodies are particularly important for CBS research to mitigate irreproducibility and clarify conflicting data that may arise from inadequate antibody characterization .

What applications are CBS antibodies commonly used for in research?

CBS antibodies have been validated for multiple research applications across various experimental systems. According to comprehensive validation data, CBS antibodies are successfully employed in:

• Western Blotting (WB): Detecting CBS protein in cell and tissue lysates with an observed molecular weight of 61-63 kDa

• Immunohistochemistry (IHC): Visualizing CBS expression in tissue sections, particularly in human pancreatic cancer, colon tissue, and other organs

• Immunofluorescence/Immunocytochemistry (IF/ICC): Determining subcellular localization in cultured cells such as HeLa cells

• Immunoprecipitation (IP): Isolating CBS protein complexes from tissue lysates, particularly from mouse kidney tissue

Multiple peer-reviewed publications have demonstrated the utility of CBS antibodies across these applications, with over 100 publications reporting successful use in Western blotting alone .

What is the expected molecular weight for CBS protein detection?

When using CBS antibodies in Western blotting applications, researchers should expect to observe a band corresponding to the CBS protein at approximately 61-63 kDa . This slight variation between calculated (61 kDa) and observed molecular weight may reflect post-translational modifications or other factors affecting protein migration in SDS-PAGE. When validating a new CBS antibody in your experimental system, confirm the detected band appears within this expected range. Additionally, CBS may appear as multiple isoforms in certain tissues or under specific conditions, which should be considered when interpreting results.

What tissues and cell lines show reliable CBS expression for positive controls?

Based on validation data, researchers can reliably detect CBS expression in the following samples when establishing positive controls:

These tissues and cell lines have demonstrated consistent CBS expression in Western blotting, immunohistochemistry, and other applications , making them suitable positive controls when establishing CBS antibody performance in new experimental systems.

How should researchers validate the specificity of CBS antibodies?

Validating antibody specificity is essential for ensuring reliable research outcomes. For CBS antibodies, implement a multi-tiered validation approach:

• Knockout/Knockdown Validation: Use CRISPR/Cas9-mediated CBS knockout cells or siRNA-mediated knockdown to confirm antibody specificity. Multiple publications have employed this approach for CBS antibody validation .

• Multiple Epitope Targeting: Use antibodies targeting spatially distant epitopes on CBS to validate detection patterns. This approach facilitates validation schemes applicable to two-site ELISA, western blotting, and immunocytochemistry .

• Epitope Mapping: When working with epitope-directed monoclonal antibodies, direct epitope mapping is crucial for antibody characterization. Using short antigenic peptides of known sequence can facilitate this process .

• Cross-Species Reactivity: Confirm reactivity across predicted species. Well-validated CBS antibodies show reactivity with human, mouse, and rat samples, with some also reacting with pig, rabbit, and canine samples .

• Multiple Detection Methods: Compare detection patterns across different methods (WB, IHC, IF) to ensure consistent results.

This comprehensive validation approach helps prevent misleading data that can arise from antibody cross-reactivity, as exemplified by controversies in other fields where inadequate antibody characterization led to questionable findings .

What are the technical considerations for detecting CBS in different subcellular compartments?

CBS has been reported to localize to different subcellular compartments depending on cell type and physiological conditions. When investigating CBS subcellular localization:

• Fixation Optimization: For immunofluorescence, compare different fixation methods (4% paraformaldehyde, methanol, or acetone) to preserve CBS epitopes while maintaining cellular architecture.

• Permeabilization Protocol: Optimize permeabilization conditions as excessive detergent treatment may disrupt nuclear membrane integrity and affect detection of nuclear CBS.

• Co-localization Studies: Employ co-localization with established organelle markers (mitochondria, nucleoli, Cajal bodies) to confirm subcellular distribution. Recent research has employed antibody-based in situ biotinylation proximity-labeling techniques to identify components of nuclear bodies that may interact with proteins like CBS .

• Subcellular Fractionation: Complement imaging studies with biochemical fractionation followed by Western blotting to quantitatively assess distribution across cellular compartments.

• Physiological Modulation: Consider that CBS localization may change in response to stress conditions, redox state, or disease states.

When publishing results, include both immunofluorescence images showing subcellular localization and corresponding Western blots of cellular fractions to provide comprehensive evidence of CBS distribution.

How can researchers distinguish between native and denatured forms of CBS using antibodies?

The conformational state of CBS can impact antibody recognition, with some antibodies preferentially binding to either native or denatured forms. To address this:

• Epitope Selection: Antibodies generated against surface-exposed epitopes typically detect native CBS, while those targeting internal sequences may preferentially detect denatured forms. Research has shown that antigenic peptides (13–24 residues long) presented as three-copy inserts on surface-exposed loops can produce antibodies reactive to both native and denatured forms of target proteins .

• Application-Specific Validation: Validate antibodies in applications that utilize native protein (IP, native PAGE) separately from those using denatured protein (SDS-PAGE, Western blot).

• Native-Condition Immunoprecipitation: When studying protein-protein interactions involving CBS, select antibodies validated for IP under native conditions.

• Conformation-Specific Detection: For investigating CBS structural changes in diseases or under stress conditions, employ antibodies that specifically recognize distinct conformational states.

• Deep Learning Approaches: Consider newer approaches using deep learning models for generating highly humanized antibody variable regions that maintain recognition properties across different protein conformations .

Understanding these distinctions is particularly important when investigating CBS's enzymatic activity, which depends on its native conformation and may be disrupted in various pathological conditions.

What methodological approaches can improve detection sensitivity for low-abundance CBS in certain tissues?

Detecting low-abundance CBS expression can be challenging in certain tissues or under specific pathological conditions. Researchers can employ these methodological refinements:

• Signal Amplification Systems: Implement tyramide signal amplification (TSA) for immunohistochemistry or detection systems with enhanced sensitivity for Western blotting.

• Sample Enrichment: Use subcellular fractionation or organelle isolation to concentrate CBS from tissues where it is expressed at low levels.

• Optimized Antigen Retrieval: For formalin-fixed tissues, test multiple antigen retrieval buffers. For CBS antibodies, TE buffer at pH 9.0 is often recommended, though citrate buffer at pH 6.0 provides an alternative approach .

• Extended Antibody Incubation: For tissues with low CBS expression, extend primary antibody incubation to overnight at 4°C with optimized antibody concentration.

• ELISA Assay Miniaturization: Novel approaches like DEXT microplates allow rapid hybridoma screening with concomitant epitope identification, potentially improving detection sensitivity for low-abundance proteins .

• Multi-omics Approaches: Consider complementing antibody-based detection with mass spectrometry or RNA-seq to confirm low-abundance expression patterns through orthogonal methods .

These approaches should be systematically optimized for each tissue type to ensure reliable detection while maintaining specificity.

What are the optimal dilution ratios for CBS antibodies across different applications?

Appropriate antibody dilution is critical for balancing specific signal with background. Based on extensive validation data, the following dilution ranges are recommended for CBS antibodies across applications:

These recommendations serve as starting points, and researchers should perform dilution series to determine optimal conditions for their specific experimental systems. The optimal dilution may vary significantly between different tissues, particularly when comparing tissues with high CBS expression (liver, kidney) versus those with lower expression levels.

What antigen retrieval methods are most effective for CBS detection in tissue sections?

Effective antigen retrieval is crucial for CBS detection in formalin-fixed, paraffin-embedded tissues. Based on validation data, the following methods have proven effective:

• Heat-Induced Epitope Retrieval (HIER):

  • Primary recommendation: TE buffer at pH 9.0

  • Alternative approach: Citrate buffer at pH 6.0

• Retrieval Conditions:

  • Duration: 15-20 minutes at sub-boiling temperature

  • Method: Pressure cooker or microwave-based systems both effective

• Tissue-Specific Considerations:

  • Pancreatic tissue: Extended retrieval time may be necessary

  • Liver tissue: Monitor carefully to prevent over-retrieval and tissue damage

  • Brain tissue: Gentler retrieval conditions may preserve morphology

• Post-Retrieval Treatment:

  • Allow sections to cool within the retrieval solution for 20 minutes

  • Rinse thoroughly in PBS before antibody application

Optimization of retrieval conditions for each tissue type is recommended, as overly harsh conditions can lead to nonspecific binding while insufficient retrieval may result in false-negative results.

How should researchers design controls for CBS antibody validation experiments?

Comprehensive controls are essential for reliable CBS antibody validation:

• Positive Controls:

  • Include tissues/cells with known high CBS expression (kidney, liver)

  • Use recombinant CBS protein at known concentrations when possible

• Negative Controls:

  • Primary antibody omission control to assess secondary antibody specificity

  • Isotype control (matched IgG) to evaluate non-specific binding

  • CBS knockout or knockdown samples (critical for definitive validation)

• Peptide Competition:

  • Pre-incubate antibody with immunizing peptide to confirm binding specificity

  • Include gradient of competing peptide concentrations to demonstrate dose-dependent inhibition

• Cross-Validation:

  • Compare results from antibodies targeting different CBS epitopes

  • Validate findings using orthogonal methods (mass spectrometry, mRNA expression)

• Reproducibility Controls:

  • Perform technical replicates across different batches of the same antibody

  • Include biological replicates to account for natural variation

Following these control practices ensures that observed CBS signals genuinely reflect the protein's expression and not technical artifacts or cross-reactivity.

What approaches should be used to quantify CBS expression in Western blot and immunohistochemistry?

Accurate quantification of CBS expression requires rigorous methodology:

For Western Blot Quantification:

• Loading Controls: Normalize CBS signal to appropriate loading controls (β-actin, GAPDH, total protein stain)

• Standard Curve: Include a concentration gradient of recombinant CBS for absolute quantification

• Dynamic Range Assessment: Ensure detection falls within the linear range of signal response

• Replicate Analysis: Perform at least three independent experiments with newly prepared lysates

• Software Analysis: Use dedicated image analysis software that corrects for background and avoids saturated pixels

For Immunohistochemistry Quantification:

• Scoring Systems: Implement semi-quantitative scoring (H-score, Allred score) for consistent evaluation

• Digital Pathology: Employ computer-assisted image analysis for objective quantification

• Region Selection: Analyze multiple representative regions to account for tissue heterogeneity

• Blinded Analysis: Have samples scored by multiple observers blinded to experimental conditions

• Statistical Validation: Apply appropriate statistical tests to verify significance of observed differences

These approaches ensure reproducible, reliable quantification of CBS expression across experimental conditions and between different researchers.

How can researchers address non-specific binding issues when using CBS antibodies?

Non-specific binding can compromise data interpretation when using CBS antibodies. Implement these troubleshooting strategies:

• Blocking Optimization:

  • Test different blocking agents (BSA, normal serum, commercial blocking buffers)

  • Extend blocking time to 2 hours at room temperature or overnight at 4°C

  • Consider adding 0.1-0.3% Triton X-100 to blocking buffer to reduce hydrophobic interactions

• Antibody Incubation Conditions:

  • Prepare antibody in fresh buffer with 0.05% Tween-20 to minimize aggregation

  • Incubate at 4°C overnight rather than at room temperature

  • Pre-absorb antibody with tissue/cell lysate from a species different from the target

• Washing Protocol Enhancement:

  • Increase wash duration and number of washes (minimum 5 washes of 5 minutes each)

  • Add increased salt concentration (up to 500 mM NaCl) to wash buffer to disrupt low-affinity interactions

  • Include 0.05-0.1% Tween-20 in wash buffer to reduce hydrophobic non-specific binding

• Secondary Antibody Considerations:

  • Use highly cross-adsorbed secondary antibodies

  • Reduce secondary antibody concentration

  • Consider fluorescent detection systems that may offer better signal-to-noise ratios

• Sample Preparation:

  • Include reducing agents in sample buffers to minimize non-specific disulfide bonding

  • Perform additional centrifugation steps to remove particulates that cause non-specific binding

These approaches should be systematically tested to identify the optimal conditions for your specific experimental system.

How do researchers interpret contradictory results between different detection methods for CBS?

Contradictory results between different detection methods (e.g., Western blot vs. IHC) can arise from various factors. To resolve such discrepancies:

• Protein Conformation Considerations:

  • Western blotting detects denatured protein while immunofluorescence often detects native forms

  • Verify whether your antibody preferentially recognizes specific conformational states

• Epitope Accessibility Analysis:

  • In fixed tissues, epitopes may be masked by protein-protein interactions or post-translational modifications

  • Test multiple antibodies targeting different CBS epitopes to compare detection patterns

• Isoform-Specific Detection:

  • Confirm whether discrepancies might result from detection of different CBS isoforms

  • Use isoform-specific antibodies or combine with RT-PCR to identify which variants are expressed

• Quantification Method Standardization:

  • Standardize quantification methods across techniques

  • Account for differences in detection sensitivity between methods

• Orthogonal Validation:

  • Employ mRNA analysis (qPCR, RNA-seq) to corroborate protein expression data

  • Consider mass spectrometry-based proteomics as an antibody-independent validation method

• Biological Context Interpretation:

  • Evaluate whether discrepancies reflect biological reality (e.g., post-transcriptional regulation)

  • Consider the subcellular localization and protein turnover rates when interpreting results

Understanding the source of contradictions can provide valuable insights into CBS biology and inform the design of more robust experimental approaches.

What are the best approaches for studying CBS in the context of protein-protein interactions?

Investigating CBS protein-protein interactions requires specialized methodological considerations:

• Co-Immunoprecipitation Optimization:

  • Use mild lysis conditions to preserve native protein complexes

  • Select antibodies validated for immunoprecipitation under native conditions

  • Consider using reversible cross-linking to stabilize transient interactions

• Proximity Labeling Techniques:

  • Implement antibody-based in situ biotinylation proximity-labeling techniques, which have been successful in identifying components of nuclear bodies

  • BioID or APEX2 approaches can reveal proteins in close proximity to CBS in living cells

• Multiplexed Co-detection:

  • Apply multi-omics analysis to identify DNA, RNA, and protein components that interact with CBS

  • Use multi-color immunofluorescence to visualize colocalization with potential interaction partners

• Functional Validation:

  • Confirm biological significance of identified interactions through functional assays

  • Employ site-directed mutagenesis to map interaction domains

• Dynamic Interaction Analysis:

  • Study how interactions change in response to stimuli or stress conditions

  • Implement live-cell imaging with proximity sensors to track temporal dynamics

These approaches allow researchers to move beyond static detection of CBS to understand its functional interactions within cellular networks.

How can deep learning approaches improve CBS antibody generation and validation?

Recent advances in computational biology are transforming antibody development and validation:

• In Silico Epitope Prediction:

  • Deep learning models can computationally generate libraries of highly humanized antibody variable regions

  • These approaches help identify optimal epitopes that balance immunogenicity with specificity

• Structural Binding Prediction:

  • Computational models predict antibody-antigen binding interfaces

  • This facilitates selection of epitopes likely to be accessible in native protein

• Cross-Reactivity Assessment:

  • Algorithms can screen for potential cross-reactivity with structurally similar proteins

  • This helps avoid issues like those seen with other antibodies that failed to distinguish between closely-related family members

• Validation Strategy Design:

  • Computational approaches guide comprehensive validation experiments

  • This ensures antibodies perform consistently across different applications

• Experimental Validation Integration:

  • Deep learning-generated antibody sequences have demonstrated successful expression in mammalian cells

  • Multiple independent laboratories have confirmed the performance of computationally designed antibodies through rigorous experimental testing

These computational approaches complement traditional antibody development methods, potentially improving both the quality and consistency of CBS antibodies available to researchers.